XML 90 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 15 - Revenue by Product Group, by Significant Customer and by Geographic Region; Geographic Information
12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
15. Revenue by Product Group, by Significant Customer and by Geographic Region; Geographic Information

Product revenue by product group is as follows:

   
Years Ended December 31,
 
   
2014
   
2013
   
2012
 
   
Revenue
   
Percentage of Product Revenue
   
Revenue
   
Percentage of Product Revenue
   
Revenue
   
Percentage of Product Revenue
 
Orthobiologics
  $ 61,956,870       82 %   $ 55,956,068       78 %   $ 49,954,112       74 %
Dermal
    1,334,295       2 %     1,816,602       3 %     1,384,403       2 %
Surgical
    5,854,876       8 %     5,445,715       8 %     5,022,456       7 %
Ophthalmic
    3,153,435       4 %     4,656,560       6 %     8,784,011       13 %
Veterinary
    3,174,522       4 %     3,898,785       5 %     2,865,187       4 %
    $ 75,473,998       100 %   $ 71,773,730       100 %   $ 68,010,169       100 %

Product revenue by significant customers as a percent of product revenues is as follows:

   
Percentage of Product Revenue
Years Ended December 31,
 
   
2014
   
2013
   
2012
 
DePuy Mitek
    72 %     63 %     61 %
Boehringer
    4 %     5 %     4 %
Medtronic XoMEd
    4 %     3 %     3 %
Bausch & Lomb
    3 %     5 %     12 %
Nordic Pharma
    2 %     2 %     1 %
      85 %     78 %     81 %

Total revenue by geographic location based on the location of the customer in total and as a percentage of total revenue are as follows:

   
Years Ended December 31,
 
   
2014
   
2013
   
2012
 
   
Revenue
   
Percentage of Total Revenue
 
Revenue
   
Percentage of Total Revenue
 
Revenue
   
Percentage of Total Revenue
 
United States
  $ 92,259,139       87 %   $ 58,490,142       78 %   $ 57,976,667       81 %
Europe
    6,214,441       6 %     7,411,568       10 %     6,218,890       9 %
Other
    7,121,259       7 %     9,179,444       12 %     7,162,948       10 %
    Total
  $ 105,594,839       100 %   $ 75,081,154       100 %   $ 71,358,505       100 %

The Company recorded licensing, milestone and contract revenue of $30,120,841, $3,307,424, and $3,348,336 for the years ended December 31, 2014, 2013, and 2012, respectively. Substantially all licensing, milestone, and contract revenue was derived in the United States for each year presented.

Net long-lived assets, consisting of net property and equipment, are subject to geographic risks because they are generally difficult to move and to effectively utilize in another geographic area in a reasonable time period and because they are relatively illiquid. Net tangible long-lived assets by principal geographic areas were as follows:

   
Years Ended December 31,
 
   
2014
   
2013
 
United States
  $ 31,058,617     $ 31,999,468  
Italy
    610,266       939,243  
  Total
  $ 31,668,883     $ 32,938,711